These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
138 related articles for article (PubMed ID: 12361839)
21. Local generation of C-reactive protein in diseased coronary artery venous bypass grafts and normal vascular tissue. Jabs WJ; Theissing E; Nitschke M; Bechtel JF; Duchrow M; Mohamed S; Jahrbeck B; Sievers HH; Steinhoff J; Bartels C Circulation; 2003 Sep; 108(12):1428-31. PubMed ID: 12975260 [TBL] [Abstract][Full Text] [Related]
22. Arterialization of human vein grafts is associated with tenascin-C expression. Wallner K; Li C; Fishbein MC; Shah PK; Sharifi BG J Am Coll Cardiol; 1999 Sep; 34(3):871-5. PubMed ID: 10483972 [TBL] [Abstract][Full Text] [Related]
23. Characterization of cellular density and determination of neointimal extracellular matrix constituents in human lower extremity vein graft stenoses. Gentile AT; Mills JL; Westerband A; Gooden MA; Berman SS; Boswell CA; Williams SK Cardiovasc Surg; 1999 Jun; 7(4):464-9. PubMed ID: 10430532 [TBL] [Abstract][Full Text] [Related]
24. Adenoviral delivery of a constitutively active retinoblastoma mutant inhibits neointima formation in a human explant model for vein graft disease. Lamfers ML; Aalders MC; Grimbergen JM; de Vries MR; Kockx MM; van Hinsbergh VW; Quax PH Vascul Pharmacol; 2002 Dec; 39(6):293-301. PubMed ID: 14567067 [TBL] [Abstract][Full Text] [Related]
25. Cytokinetic study of aortocoronary bypass vein grafts in place for less than six months. Amano J; Suzuki A; Sunamori M; Tsukada T; Numano F Am J Cardiol; 1991 Jun; 67(15):1234-6. PubMed ID: 2035447 [TBL] [Abstract][Full Text] [Related]
26. Role of osteopontin in the development of neointimal hyperplasia in vein grafts. Kang N; Ng CS; Hu J; Qiu ZB; Underwood MJ; Jeremy JY; Wan S Eur J Cardiothorac Surg; 2012 Jun; 41(6):1384-9. PubMed ID: 22219474 [TBL] [Abstract][Full Text] [Related]
28. Loss of p53 accelerates neointimal lesions of vein bypass grafts in mice. Mayr U; Mayr M; Li C; Wernig F; Dietrich H; Hu Y; Xu Q Circ Res; 2002 Feb; 90(2):197-204. PubMed ID: 11834713 [TBL] [Abstract][Full Text] [Related]
29. Immunohistochemical and ultrastructural examination of smooth muscle cells in aortocoronary saphenous vein grafts. Yamada T; Shiraishi R; Taki K; Nakano S; Tokunaga O; Itoh T Angiology; 1997 May; 48(5):381-90. PubMed ID: 9158382 [TBL] [Abstract][Full Text] [Related]
30. An immunocytochemical analysis of rapidly progressive atherosclerosis in human vein grafts. van der Wal AC; Becker AE; Elbers JR; Das PK Eur J Cardiothorac Surg; 1992; 6(9):469-73; discussion 474. PubMed ID: 1389257 [TBL] [Abstract][Full Text] [Related]
31. Early growth response gene-1 decoy oligonucleotides inhibit vascular smooth muscle cell proliferation and neointimal hyperplasia of autogenous vein graft in rabbits. Wang X; Mei Y; Ji Q; Feng J; Cai J; Xie S Interact Cardiovasc Thorac Surg; 2015 Jul; 21(1):50-4. PubMed ID: 25820759 [TBL] [Abstract][Full Text] [Related]
32. Smoothelin and intermediate filament proteins in human aortocoronary saphenous vein by-pass grafts. Johansson B; Eriksson A; Ramaekers F; Thornell LE Histochem J; 1999 Nov; 31(11):723-7. PubMed ID: 10646837 [TBL] [Abstract][Full Text] [Related]
33. Histological and morphometric analyses of early and late aortocoronary vein grafts and distal anastomoses. Butany JW; David TE; Ojha M Can J Cardiol; 1998 May; 14(5):671-7. PubMed ID: 9627522 [TBL] [Abstract][Full Text] [Related]
34. Preoperative factors predicting saphenous vein graft occlusion in coronary artery bypass grafting: a multivariate analysis. Malinska A; Podemska Z; Perek B; Jemielity M; Buczkowski P; Grzymislawska M; Sujka-Kordowska P; Nowicki M Histochem Cell Biol; 2017 Oct; 148(4):417-424. PubMed ID: 28478589 [TBL] [Abstract][Full Text] [Related]
35. Early remodeling of saphenous vein grafts: proliferation, migration and apoptosis of adventitial and medial cells occur simultaneously with changes in graft diameter and blood flow. Kalra M; Miller VM J Vasc Res; 2000; 37(6):576-84. PubMed ID: 11146412 [TBL] [Abstract][Full Text] [Related]
36. [Early changes at anastomotic sites of saphenous vein grafts after coronary artery bypass grafting]. Sasaki Y; Ueda M; Suehiro S; Shibata T; Minamimura H; Hattori K; Kinoshita H Nihon Geka Gakkai Zasshi; 1995 Jul; 96(7):466-72. PubMed ID: 7675025 [TBL] [Abstract][Full Text] [Related]
38. Cytokeratin 8 in venous grafts: a factor of unfavorable long-term prognosis in coronary artery bypass grafting patients. Perek B; Malińska A; Ostalska-Nowicka D; Puślecki M; Ligowski M; Misterski M; Zabel M; Jemielity M; Nowicki M Cardiol J; 2013; 20(6):583-91. PubMed ID: 24338534 [TBL] [Abstract][Full Text] [Related]
39. Histopathological study of aorto-coronary bypass grafts with special reference to fibrin deposits on grafted saphenous veins. Yutani C; Imakita M; Ishibashi-Ueda H Acta Pathol Jpn; 1989 Jul; 39(7):425-32. PubMed ID: 2801113 [TBL] [Abstract][Full Text] [Related]
40. The effect of coronary reoperation on the survival of patients with stenoses in saphenous vein bypass grafts to coronary arteries. Lytle BW; Loop FD; Taylor PC; Goormastic M; Stewart RW; Novoa R; McCarthy P; Cosgrove DM J Thorac Cardiovasc Surg; 1993 Apr; 105(4):605-12; discussion 612-4. PubMed ID: 8468995 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]